LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced two key hires to its management team. Dr. Anthony Williams has joined Synta as Vice President of Clinical Research and Mary Drummond has joined the Company as Director of Commercial Development for Oncology.
